University Health Network
Toronto, Ontario, M5G 2C4, Canada
NCT Number: NCT02560844
This study will evaluate the prognostic utility of novel ECG markers of electrical instability in patients with cardiomyopathy.
Looking for future studies?
Notify MeAll sexes
Observational
Toronto, Ontario, M5G 2C4, Canada
Baseline ECG markers of electrical instability will be measured in patients with cardiomyopathy. These ECG markers will be evaluated from a clinical Holter recording. All patients will have a primary implantable cardioverter defibrillator (ICD) as part of their clinical care. Patients will be followed prospectively for 2 years to evaluate the primary outcome of appropriate ICD shocks. Multivariable modelling will be performed to determine whether the ECG markers of electrical instability independently predict the primary clinical outcome.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
Proportion is from 0 (no patients with shocks) to 100% (all patients receive shocks)
University Health Network, Toronto
Other
Acronym: CARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03057561
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT01143519
Cancer, Cardiomyopathies
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT07272330
Cardiomyopathies, Cardiomyopathy
Beijing, Beijing Municipality, China
View Trial DetailsNCT01648634
Cardiomyopathies, Cardiomyopathy
Paris, France
View Trial Details